BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26847067)

  • 1. Opposite RHOA functions within the ATLL category.
    Ishikawa S
    Blood; 2016 Feb; 127(5):524-5. PubMed ID: 26847067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variegated RHOA mutations in adult T-cell leukemia/lymphoma.
    Nagata Y; Kontani K; Enami T; Kataoka K; Ishii R; Totoki Y; Kataoka TR; Hirata M; Aoki K; Nakano K; Kitanaka A; Sakata-Yanagimoto M; Egami S; Shiraishi Y; Chiba K; Tanaka H; Shiozawa Y; Yoshizato T; Suzuki H; Kon A; Yoshida K; Sato Y; Sato-Otsubo A; Sanada M; Munakata W; Nakamura H; Hama N; Miyano S; Nureki O; Shibata T; Haga H; Shimoda K; Katada T; Chiba S; Watanabe T; Ogawa S
    Blood; 2016 Feb; 127(5):596-604. PubMed ID: 26574607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cells.
    Chiba S; Enami T; Ogawa S; Sakata-Yanagimoto M
    Small GTPases; 2015; 6(2):100-3. PubMed ID: 26103434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.
    Yoshida N; Miyoshi H; Kato T; Sakata-Yanagimoto M; Niino D; Taniguchi H; Moriuchi Y; Miyahara M; Kurita D; Sasaki Y; Shimono J; Kawamoto K; Utsunomiya A; Imaizumi Y; Seto M; Ohshima K
    J Pathol; 2016 Apr; 238(5):621-6. PubMed ID: 26847489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.
    Ohshima K; Haraoka S; Yoshioka S; Hamasaki M; Fujiki T; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
    Cancer Lett; 2000 Oct; 158(2):141-50. PubMed ID: 10960763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RHOA Therapeutic Targeting in Hematological Cancers.
    Santos JC; Profitós-Pelejà N; Sánchez-Vinces S; Roué G
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
    Hatta Y; Koeffler HP
    Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
    Tanzima Nuhat S; Sakata-Yanagimoto M; Komori D; Hattori K; Suehara Y; Fukumoto K; Fujisawa M; Kusakabe M; Matsue K; Wakamatsu H; Shimadzu M; Chiba S
    Cancer Sci; 2018 May; 109(5):1682-1689. PubMed ID: 29493850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
    Lee PH; Weng SW; Liu TT; You HL; Liao CK; Wang MC; Huang WT
    Exp Mol Pathol; 2019 Oct; 110():104294. PubMed ID: 31394087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies.
    Shah UA; Chung EY; Giricz O; Pradhan K; Kataoka K; Gordon-Mitchell S; Bhagat TD; Mai Y; Wei Y; Ishida E; Choudhary GS; Joseph A; Rice R; Gitego N; Parrish C; Bartenstein M; Goel S; Mantzaris I; Shastri A; Derman O; Binder A; Gritsman K; Kornblum N; Braunschweig I; Bhagat C; Hall J; Graber A; Ratner L; Wang Y; Ogawa S; Verma A; Ye BH; Janakiram M
    Blood; 2018 Oct; 132(14):1507-1518. PubMed ID: 30104217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols.
    Rohde M; Richter J; Schlesner M; Betts MJ; Claviez A; Bonn BR; Zimmermann M; Damm-Welk C; Russell RB; Borkhardt A; Eils R; Hoell JI; Szczepanowski M; Oschlies I; Klapper W; Burkhardt B; Siebert R; ;
    Genes Chromosomes Cancer; 2014 Nov; 53(11):911-6. PubMed ID: 25044415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variegated RHOA mutations in human cancers.
    Kataoka K; Ogawa S
    Exp Hematol; 2016 Dec; 44(12):1123-1129. PubMed ID: 27693615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylated STAT3 expression predicts better prognosis in smoldering type of adult T-cell leukemia/lymphoma.
    Morichika K; Karube K; Kayo H; Uchino S; Nishi Y; Nakachi S; Okamoto S; Morishima S; Ohshiro K; Nakazato I; Fukushima T; Masuzaki H
    Cancer Sci; 2019 Sep; 110(9):2982-2991. PubMed ID: 31237072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of NDRG2 expression during ATLL development after HTLV-1 infection.
    Ichikawa T; Nakahata S; Fujii M; Iha H; Shimoda K; Morishita K
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2633-2646. PubMed ID: 31295529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma.
    Nakahata S; Saito Y; Hamasaki M; Hidaka T; Arai Y; Taki T; Taniwaki M; Morishita K
    Genes Chromosomes Cancer; 2009 Sep; 48(9):768-76. PubMed ID: 19484761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.
    Nakagawa M; Schmitz R; Xiao W; Goldman CK; Xu W; Yang Y; Yu X; Waldmann TA; Staudt LM
    J Exp Med; 2014 Dec; 211(13):2497-505. PubMed ID: 25488980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation Analysis for TP53 in Chronic-Type Adult T-Cell Leukemia/Lymphoma.
    Yoshida N; Imaizumi Y; Utsunomiya A; Miyoshi H; Arakawa F; Tsukasaki K; Ohshima K; Seto M
    J Clin Exp Hematop; 2015; 55(1):13-6. PubMed ID: 26106001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
    Ohshima K
    Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia/lymphoma.
    Hashikawa K; Yasumoto S; Nakashima K; Arakawa F; Kiyasu J; Kimura Y; Saruta H; Nakama T; Yasuda K; Tashiro K; Kuhara S; Hashimoto T; Ohshima K
    Int J Oncol; 2014 Sep; 45(3):1200-8. PubMed ID: 24970722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
    Shimosaki S; Nakahata S; Ichikawa T; Kitanaka A; Kameda T; Hidaka T; Kubuki Y; Kurosawa G; Zhang L; Sudo Y; Shimoda K; Morishita K
    Biochem Biophys Res Commun; 2017 Mar; 485(1):144-151. PubMed ID: 28189691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.